-
Beijing E-Town launches dialogue activities with foreign-funded enterprises
2023-01-28
Zheng Haitao, deputy director of the Beijing E-Town Administrative Committee, met with Pierre-Yves Guidi, global operations director of B.E.A Electronics (Beijing) Co, via video link on Jan 17, which is one of a series of dialogue activities between Beijing E-Town and the headquarters of foreign-funded enterprises in 2023.
-
Beijing E-Town's contribution in Beijing's GIHI ranking
2023-01-03
The Center for Industrial Development and Environmental Governance of Tsinghua University (CIDEG) and Nature Research recently released the Global Innovation Hubs Index (GIHI).
-
36 million yuan in subsidies to be issued to technology firms
2022-12-27
Recently, Beijing E-Town announced the first batch of technology enterprises subsidies, and it is expected that 1,448 companies will receive over 36 million yuan ($5.16 million) in production resumption subsidies.
-
Beijing E-Town issues first business license for directly changing operators
2022-12-19
"I thought it would take at least two more trips to get the business license and food business license, but I didn't expect the efficiency to be so high, and that it would all be done on the same day", said Mr. Ma, who came to go through the formalities of changing the operator of an individual industrial and commercial household, and was both excited and satisfied with his certificate in hand.
-
Actual utilization of foreign capital in Beijing E-Town increases steadily
2022-12-16
From January to September, the actual use of foreign capital in Beijing E-Town steadily increased throughout 2022, with a year-on-year increase of more than 100 percent.
-
Beijing's first skyscraper factory completed
2022-12-14
After 18 months of construction, the Sky Realm·Industrial Plaza project, Beijing's first skyscraper factory, was completed.
-
Five hundred million yuan invested, new medicine production lines in Beijing E-Town
2022-11-22
"We decided to invest 500 million yuan ($70.05 million) to build a Soliqua™ (insulin glargine lixisenatide injection) product filling and assembly production line at Sanofi (Beijing) Pharmaceutical's insulin production base to further ensure the supply of innovative products." said Shi Wang, president of Sanofi Greater China.
-
First RCEP Customs Brokers Association International Forum held
2022-11-14
The first RCEP Customs Brokers Association International Forum kicked off on Nov 7.